April 22, 2014 | Three weeks ago, the European Parliament voted to adopt a trial transparency system similar to that in the U.S., where all clinical trials must be publicly announced in advance, and all results made freely available online within a reasonable timeframe. As the European Medicine Agency prepares to fine tune the policy details next month, Outsourcing Pharma examines the kinks that still need to be worked out, including whether competitive information can be redacted. Outsourcing Pharma